SCHEMBL1395381

SCHEMBL1395381

CCC(C(=O)O)n1nnc(-c2cnc(Cl)nc2)n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
KDM4E B2RXH2 2/20 0.58
MAPK1 P28482 2/20 0.58
HPGD P15428 1/20 0.58
HSD17B10 Q99714 1/20 0.58
NPSR1 Q6W5P4 1/20 0.38
CYP2C9 P11712 2/20 0.35
USP2 O75604 1/20 0.35
TP53 P04637 1/20 0.35
CYP1A2 P05177 1/20 0.35
ALOX15 P16050 1/20 0.35
CASP3 P42574 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35
AKR1C3 P42330 1/20 0.35
AKR1C2 P52895 1/20 0.35
LTA4H P09960 2/20 0.34
MAPT P10636 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1393716 0.86 SMN1; SMN2 (0.58) ALDH1A1SMN1; SMN2KDM4EMAPK1HPGD
SCHEMBL14629954 0.82 ALDH1A1 (0.70) ALDH1A1SMN1; SMN2KDM4EMAPK1HPGD
SCHEMBL1394766 0.78 SMN1; SMN2 (0.53) ALDH1A1SMN1; SMN2KDM4EMAPK1HPGD
Hydrochloric Acid SCHEMBL3711354 0.78 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2KDM4EMAPK1HPGD
SCHEMBL1969495 0.77 KDM4E (0.46) ALDH1A1SMN1; SMN2KDM4EMAPK1HPGD
SCHEMBL1967150 0.76 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2KDM4EMAPK1HPGD
SCHEMBL1238494 0.75 KDM4E (0.51) ALDH1A1SMN1; SMN2KDM4EMAPK1HPGD
SCHEMBL1987294 0.74 MAPK1 (0.53) ALDH1A1SMN1; SMN2KDM4EMAPK1HPGD
SCHEMBL3715973 0.73 MEN1 (0.56) ALDH1A1HPGDLTA4HMAPTGAA
SCHEMBL10111878 0.71 NPC1 (0.55) ALDH1A1SMN1; SMN2HPGDHSD17B10NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120010186-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2012-01-12 US disclosed
WO-2011047481-A1 NOVEL SPIRO COMPOUNDS USEFUL AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2011-04-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010186-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE SCD, SCD5, FASN ALDH1A1 544/4885SMN1; SMN2 2174/4885KDM4E 1727/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.